Oracle (NYSE:ORCL) Trading Down 9.7% After Insider Selling

Oracle Co. (NYSE:ORCLGet Free Report)’s stock price dropped 9.7% during trading on Monday after an insider sold shares in the company. The stock traded as low as $166.13 and last traded at $165.72. Approximately 11,780,896 shares changed hands during trading, a decline of 11% from the average daily volume of 13,269,305 shares. The stock had previously closed at $183.60.

Specifically, CEO Safra Catz sold 2,101,154 shares of Oracle stock in a transaction dated Wednesday, January 22nd. The stock was sold at an average price of $185.35, for a total transaction of $389,448,893.90. Following the completion of the sale, the chief executive officer now directly owns 1,118,592 shares of the company’s stock, valued at $207,331,027.20. The trade was a 65.26 % decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available at this link. Also, CEO Safra Catz sold 345,174 shares of the company’s stock in a transaction on Friday, January 24th. The shares were sold at an average price of $185.56, for a total transaction of $64,050,487.44. Following the completion of the transaction, the chief executive officer now owns 1,118,592 shares of the company’s stock, valued at approximately $207,565,931.52. The trade was a 23.58 % decrease in their position. The disclosure for this sale can be found here.

Wall Street Analyst Weigh In

A number of research analysts have commented on the stock. Evercore ISI lifted their price objective on shares of Oracle from $190.00 to $200.00 and gave the company an “outperform” rating in a research note on Tuesday, December 10th. Jefferies Financial Group boosted their target price on shares of Oracle from $190.00 to $220.00 and gave the stock a “buy” rating in a research report on Thursday, December 5th. BMO Capital Markets upped their price target on Oracle from $173.00 to $205.00 and gave the stock a “market perform” rating in a report on Tuesday, December 10th. UBS Group lifted their target price on shares of Oracle from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Tuesday, December 10th. Finally, Citigroup boosted their price target on Oracle from $157.00 to $194.00 and gave the stock a “neutral” rating in a report on Tuesday, December 10th. One equities research analyst has rated the stock with a sell rating, eleven have assigned a hold rating, seventeen have assigned a buy rating and two have issued a strong buy rating to the company. Based on data from MarketBeat.com, Oracle currently has a consensus rating of “Moderate Buy” and an average price target of $182.73.

Read Our Latest Stock Analysis on ORCL

Oracle Price Performance

The business’s 50 day moving average price is $173.85 and its 200-day moving average price is $162.89. The company has a quick ratio of 0.81, a current ratio of 0.81 and a debt-to-equity ratio of 5.65. The company has a market cap of $459.04 billion, a PE ratio of 40.13, a price-to-earnings-growth ratio of 3.62 and a beta of 1.06.

Oracle (NYSE:ORCLGet Free Report) last released its quarterly earnings results on Monday, December 9th. The enterprise software provider reported $1.47 earnings per share (EPS) for the quarter, missing the consensus estimate of $1.48 by ($0.01). The firm had revenue of $14.06 billion for the quarter, compared to analysts’ expectations of $14.12 billion. Oracle had a return on equity of 133.25% and a net margin of 21.16%. The business’s quarterly revenue was up 8.6% on a year-over-year basis. During the same period last year, the firm earned $1.34 EPS. As a group, analysts forecast that Oracle Co. will post 5.01 earnings per share for the current year.

Oracle Dividend Announcement

The firm also recently disclosed a quarterly dividend, which was paid on Thursday, January 9th. Shareholders of record on Thursday, January 23rd were paid a dividend of $0.40 per share. The ex-dividend date was Friday, January 10th. This represents a $1.60 dividend on an annualized basis and a yield of 0.97%. Oracle’s dividend payout ratio (DPR) is presently 39.12%.

Hedge Funds Weigh In On Oracle

Institutional investors have recently made changes to their positions in the business. Activest Wealth Management raised its position in shares of Oracle by 21.9% during the third quarter. Activest Wealth Management now owns 312 shares of the enterprise software provider’s stock valued at $53,000 after buying an additional 56 shares during the last quarter. Second Line Capital LLC raised its holdings in Oracle by 1.5% in the 3rd quarter. Second Line Capital LLC now owns 3,816 shares of the enterprise software provider’s stock valued at $650,000 after acquiring an additional 58 shares in the last quarter. Cadence Bank lifted its position in shares of Oracle by 0.8% in the 3rd quarter. Cadence Bank now owns 7,605 shares of the enterprise software provider’s stock worth $1,296,000 after acquiring an additional 59 shares during the period. Requisite Capital Management LLC increased its position in shares of Oracle by 2.8% during the fourth quarter. Requisite Capital Management LLC now owns 2,240 shares of the enterprise software provider’s stock valued at $373,000 after purchasing an additional 60 shares during the period. Finally, McLean Asset Management Corp raised its stake in shares of Oracle by 1.1% in the fourth quarter. McLean Asset Management Corp now owns 5,447 shares of the enterprise software provider’s stock valued at $908,000 after purchasing an additional 61 shares in the last quarter. 42.44% of the stock is owned by institutional investors and hedge funds.

About Oracle

(Get Free Report)

Oracle Corporation offers products and services that address enterprise information technology environments worldwide. Its Oracle cloud software as a service offering include various cloud software applications, including Oracle Fusion cloud enterprise resource planning (ERP), Oracle Fusion cloud enterprise performance management, Oracle Fusion cloud supply chain and manufacturing management, Oracle Fusion cloud human capital management, Oracle Cerner healthcare, Oracle Advertising, and NetSuite applications suite, as well as Oracle Fusion Sales, Service, and Marketing.

Read More

Receive News & Ratings for Oracle Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oracle and related companies with MarketBeat.com's FREE daily email newsletter.